APA (7th ed.) Citation

CY, W., KH, T., CH, C., YH, C., SA, L., CY, C., & CJ, L. (2022). Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma. Journal of oncology, 2022, 9854788. https://doi.org/10.1155/2022/9854788

Chicago Style (17th ed.) Citation

CY, Wen, Tsui KH, Chang CH, Chiu YH, Lin SA, Chu CY, and Li CJ. "Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That Is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma." Journal of Oncology 2022 (2022): 9854788. https://doi.org/10.1155/2022/9854788.

MLA (9th ed.) Citation

CY, Wen, et al. "Integrative Multiomics Evaluation of IIDH1 Metabolic Enzyme as a Candidate Oncogene That Is Correlated with Poor Prognosis and Immune Infiltration in Prostate Adenocarcinoma." Journal of Oncology, vol. 2022, 2022, p. 9854788, https://doi.org/10.1155/2022/9854788.